Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03427476
What this trial is testing

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cancer Targeted Technology 4
Testing effectiveness (Phase 2)Study completedNCT00444314
What this trial is testing

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
CASI pharmaceuticals, Inc. 82
Not applicableStudy completedNCT06775158
What this trial is testing

Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection

Who this might be right for
Liver NeoplasmKidney Injury, AcuteMyocardial Injury After Non-Cardiac Surgery
Istanbul Saglik Bilimleri University 128
Early research (Phase 1)Looking for participantsNCT05868174
What this trial is testing

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorAdvanced Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 36
Not applicableStudy completedNCT01585974
What this trial is testing

Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bayer 151
Early research (Phase 1)Looking for participantsNCT04989959
What this trial is testing

[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Orhan Kemal Oz 35
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Not applicableLooking for participantsNCT03804320
What this trial is testing

Protocol Active Surveillance Small Renal Masses (SRMs)

Who this might be right for
Kidney Cancer
IRCCS San Raffaele 180
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Testing effectiveness (Phase 2)Looking for participantsNCT07223424
What this trial is testing

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Who this might be right for
Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more
Diwakar Davar 880
Not applicableActive Not RecruitingNCT07101913
What this trial is testing

Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.

Who this might be right for
Acute Kidney Injury (AKI)Infusion of CD19 CAR T CellB Cell Lymphoma
Hospices Civils de Lyon 300
Not applicableUnknownNCT06148220
What this trial is testing

The Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Who this might be right for
Kidney CancerLymphomasPositron Emission Tomography
Huashan Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00591188
What this trial is testing

Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens

Who this might be right for
Carcinoma, Renal Cell
Kidney Cancer Research Bureau 49
Testing effectiveness (Phase 2)UnknownNCT03633773
What this trial is testing

Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT06138496
What this trial is testing

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 39
Not applicableStudy completedNCT01411423
What this trial is testing

Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan

Who this might be right for
Carcinoma, Renal Cell
Bayer 3,305
Not applicableStudy completedNCT07833124
What this trial is testing

Multiphase CT Deep Learning for Bosniak II-III Renal Cysts

Who this might be right for
Renal Cyst
Shanghai Zhongshan Hospital 223
Not applicableEnded earlyNCT01117779
What this trial is testing

Tracking Renal Tumors After Cryoablation Evaluation

Who this might be right for
Kidney Neoplasms
Boston Scientific Corporation 246
Not applicableUnknownNCT02041559
What this trial is testing

The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study

Who this might be right for
Prostate Cancer
Yonsei University 1,500
Testing effectiveness (Phase 2)Study completedNCT02862288
What this trial is testing

Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.

Who this might be right for
Lung TumorBone TumorRenal Tumor
Centre Hospitalier Universitaire de Besancon 30
Next Page